| Literature DB >> 19814668 |
Nora Sandu1, Jan Cornelius, Andreas Filis, Belachew Arasho, Miguel Perez-Pinzon, Bernhard Schaller.
Abstract
Although outcome after stroke treatment has significantly improved over the last 30 years, there has been no revolutionary breakthrough. Among different combined approaches, systemic thrombolysis in combination with neuroprotection became a favorite research target. Recent studies suggest that transient ischemic attacks may represent a clinical model of such ischemic tolerance; thus, a new focus on this research has emerged. In this review, we show the parallels between ischemia and neuroprotection and discuss the potential therapeutic options that may be opened by this new molecular knowledge.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19814668 PMCID: PMC2881628 DOI: 10.1586/erc.09.90
Source DB: PubMed Journal: Expert Rev Cardiovasc Ther ISSN: 1477-9072